TRIVARX LTD - Announcements

0.00%

1.1¢

Market Cap $6.818M

Healthcare Biotechnology

TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology... TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is development of artificial intelligence (AI)-driven, scientifically based devices for screening and diagnosis of behavioral health conditions. Its clinical research has enabled the development of proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The Company’s lead product, MEB-001 analyses the data from a standard sleep study to identify depression at a sensitivity of over 85%. Its technology analyses the electrical signals from the brain and the heart to identify mental illness.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

TRI	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	29/08/25	351.58KB	Share
TRI	June 2025 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/25	356.68KB	Share
TRI	First patient recruited in innovative mental health trial	PRICE SENSITIVE	19/06/25	127.34KB	Share
TRI	March 2025 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/04/25	355.85KB	Share
TRI	IRB approval for trial with US Dept of Veterans Affairs	PRICE SENSITIVE	28/04/25	132.57KB	Share
TRI	TrivarX Receives Firm Commitments to Raise $2.25 million	PRICE SENSITIVE	17/03/25	137.35KB	Share
TRI	Trading Halt	PRICE SENSITIVE	13/03/25	255.86KB	Share
TRI	Trial with US Department of Veterans Affairs	PRICE SENSITIVE	13/03/25	137.48KB	Share
TRI	Appendix 4D & Half-Year Financial Report to 31 December 2024	PRICE SENSITIVE	28/02/25	855.59KB	Share
TRI	December 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/25	377.14KB	Share
TRI	TrivarX Receives $1.03m R&D Tax Incentive	PRICE SENSITIVE	06/12/24	116.48KB	Share
TRI	New AI Tool Expands Patient Reach and Market Opportunities	PRICE SENSITIVE	07/11/24	179.46KB	Share
TRI	September 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/10/24	379.85KB	Share
TRI	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	29/08/24	340.77KB	Share
TRI	June 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/24	403.3KB	Share
TRI	Positive Results from Phase 2 SAMDE Study	PRICE SENSITIVE	30/07/24	199.35KB	Share
TRI	Trading Halt	PRICE SENSITIVE	29/07/24	256.67KB	Share
TRI	TrivarX Receives Firm Commitments to Raise $2.5 million	PRICE SENSITIVE	02/05/24	146.08KB	Share
TRI	Trading Halt	PRICE SENSITIVE	30/04/24	255.74KB	Share
TRI	March 2024 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/04/24	384.67KB	Share
TRI	Appendix 4D & Half-Year Financial Report to 31 December 2023	PRICE SENSITIVE	28/02/24	773.88KB	Share
TRI	Response to ASX Price Query	PRICE SENSITIVE	22/02/24	340.86KB	Share
TRI	TrivarX Receives $888k R&D Tax Incentive	PRICE SENSITIVE	08/02/24	102.8KB	Share
TRI	TRI-001 Algorithm and Phase 2 Trial Update	PRICE SENSITIVE	05/02/24	160.46KB	Share
TRI	December 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/24	275.48KB	Share
TRI	Phase 2 SAMDE Study Update	PRICE SENSITIVE	20/11/23	153.22KB	Share
TRI	September 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	30/10/23	256.22KB	Share
TRI	Board and Management Transition	PRICE SENSITIVE	06/10/23	159.19KB	Share
TRI	Letter to Shareholders & Notice of GM & Proxy Form	PRICE SENSITIVE	06/09/23	821.04KB	Share
TRI	Phase 2 Trial Commences for SAMDE Study	PRICE SENSITIVE	04/09/23	206.53KB	Share
TRI	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	31/08/23	343.63KB	Share
TRI	Proposed issue of securities - MEB	PRICE SENSITIVE	07/08/23	34.7KB	Share
TRI	Medibio Receives Firm Commitments to Raise $2.25m	PRICE SENSITIVE	07/08/23	190.07KB	Share
TRI	Trading Halt	PRICE SENSITIVE	03/08/23	272.13KB	Share
TRI	June 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/07/23	415.98KB	Share
TRI	Phase 1 Trial Completed for SAMDE Study	PRICE SENSITIVE	24/07/23	207.02KB	Share
TRI	Medibio Completes Share Purchase Plan	PRICE SENSITIVE	29/05/23	149.36KB	Share
TRI	March 2023 Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	27/04/23	399.18KB	Share
TRI	MEB Executes Bridging Loans with Directors	PRICE SENSITIVE	21/04/23	143.06KB	Share
TRI	Share Purchase Plan Supplementary Prospectus	PRICE SENSITIVE	14/04/23	1.6MB	Share
TRI	Share Purchase Plan Prospectus	PRICE SENSITIVE	02/03/23	575.38KB	Share
TRI	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/23	701.09KB	Share
TRI	MEB to Raise up to $2.75 million By Way of a Placement & SPP	PRICE SENSITIVE	15/02/23	297.63KB	Share
TRI	Trading Halt	PRICE SENSITIVE	10/02/23	244.18KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	31/01/23	419.7KB	Share
TRI	Medibio Receives R&D Tax Incentive Refund	PRICE SENSITIVE	15/11/22	141.04KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	31/10/22	416.29KB	Share
TRI	Medibio Appoints CEO	PRICE SENSITIVE	19/09/22	219.57KB	Share
TRI	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	31/08/22	269.04KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	01/08/22	398.62KB	Share
TRI	Sleep Analysis Depressive Burden Study Clinical Trial	PRICE SENSITIVE	21/07/22	133.4KB	Share
TRI	MEB to Raise $1.4m by way of a Placement & MD/CEO Resigns	PRICE SENSITIVE	22/06/22	175.97KB	Share
TRI	Reinstatement to Quotation	PRICE SENSITIVE	22/06/22	85.48KB	Share
TRI	Voluntary Suspension	PRICE SENSITIVE	16/06/22	208.9KB	Share
TRI	Trading Halt	PRICE SENSITIVE	14/06/22	505.79KB	Share
TRI	FDA Confirm Diagnostic Method on Depression Validation Trial	PRICE SENSITIVE	18/05/22	218.87KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	29/04/22	386.76KB	Share
TRI	Medibio Announces Entitlement Offer Result	PRICE SENSITIVE	11/03/22	112.23KB	Share
TRI	Termination of Underwriting Agreement	PRICE SENSITIVE	01/03/22	172.77KB	Share
TRI	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/22	603.03KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	31/01/22	567.09KB	Share
TRI	Non-Renounceable Entitlement Offer Underwriting Update	PRICE SENSITIVE	20/01/22	163.85KB	Share
TRI	MEB to Raise up to $5.7 million by way of a Placement & NREO	PRICE SENSITIVE	15/12/21	313.46KB	Share
TRI	Trading Halt	PRICE SENSITIVE	10/12/21	333.12KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	29/10/21	422.62KB	Share
TRI	FDA Strategy and Regulatory Update	PRICE SENSITIVE	26/10/21	294.24KB	Share
TRI	Appendix 4E and Annual Report	PRICE SENSITIVE	31/08/21	1.16MB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	30/07/21	369.51KB	Share
TRI	MEB Appoints R&CPMK As Communications Agency in the US	PRICE SENSITIVE	25/06/21	191.45KB	Share
TRI	Medibio strengthens its IP protection	PRICE SENSITIVE	04/05/21	138.49KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	30/04/21	397.8KB	Share
TRI	Re-submission of FDA 510(k) application	PRICE SENSITIVE	29/04/21	159.75KB	Share
TRI	Consumer Mental Health App Development - Second Test Phase	PRICE SENSITIVE	22/04/21	167.63KB	Share
TRI	MEB Share Purchase Plan Closes Strongly Oversubscribed	PRICE SENSITIVE	31/03/21	181.59KB	Share
TRI	Supplementary Prospectus	PRICE SENSITIVE	31/03/21	184.81KB	Share
TRI	MEB Begins Implementation of ilumen In the United Kingdom	PRICE SENSITIVE	19/03/21	220.5KB	Share
TRI	Share Purchase Plan Prospectus	PRICE SENSITIVE	26/02/21	860.18KB	Share
TRI	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/21	582.16KB	Share
TRI	Underwritten Share Purchase Plan Update	PRICE SENSITIVE	15/02/21	167.32KB	Share
TRI	MEB to Raise up to $3.5m By Way of a Placement and SPP	PRICE SENSITIVE	10/02/21	260.39KB	Share
TRI	Trading Halt	PRICE SENSITIVE	05/02/21	195.53KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	29/01/21	433.04KB	Share
TRI	Medibio Granted CE Mark Approval for MEBsleep	PRICE SENSITIVE	19/01/21	106.21KB	Share
TRI	Consumer Mental Health App Initial testing phase commenced	PRICE SENSITIVE	11/01/21	106.75KB	Share
TRI	US FDA advises further data needed for MEBsleep approval	PRICE SENSITIVE	29/12/20	188.85KB	Share
TRI	Update on Breakthrough Device Program	PRICE SENSITIVE	03/12/20	108.09KB	Share
TRI	Global Master License & Services Agreement with Compass	PRICE SENSITIVE	23/11/20	196.92KB	Share
TRI	AGM Presentation	PRICE SENSITIVE	12/11/20	1.19MB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	29/10/20	225.26KB	Share
TRI	MEB Signs Clinical Trial Agreement with MedBridge Healthcare	PRICE SENSITIVE	07/10/20	231.79KB	Share
TRI	Request For FDA Breakthrough Device Designation Submitted	PRICE SENSITIVE	02/10/20	142.79KB	Share
TRI	FDA Strategy and Regulatory Update	PRICE SENSITIVE	31/08/20	189.16KB	Share
TRI	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	28/08/20	336.33KB	Share
TRI	Patent Granted to Monitor Stress Conditions Using Heartrate	PRICE SENSITIVE	10/08/20	177.71KB	Share
TRI	FDA Strategy and Regulatory Update	PRICE SENSITIVE	07/08/20	193.82KB	Share
TRI	Medibio Quarterly Update and Cashflow Report	PRICE SENSITIVE	30/07/20	453.75KB	Share
TRI	Entitlement Issue Results	PRICE SENSITIVE	09/07/20	142.68KB	Share
TRI	Entitlement Offer Booklet	PRICE SENSITIVE	10/06/20	605.3KB	Share
TRI	Placement and Fully Underwritten Entitlement Offer	PRICE SENSITIVE	10/06/20	166.07KB	Share
TRI	Trading Halt	PRICE SENSITIVE	05/06/20	205.31KB	Share

TRI Appendix 4E - Preliminary Final Report
29/08/25	PRICE SENSITIVE	351.58KB	Share
TRI June 2025 Quarterly Activities Report and Appendix 4C
31/07/25	PRICE SENSITIVE	356.68KB	Share
TRI First patient recruited in innovative mental health trial
19/06/25	PRICE SENSITIVE	127.34KB	Share
TRI March 2025 Quarterly Activities Report and Appendix 4C
30/04/25	PRICE SENSITIVE	355.85KB	Share
TRI IRB approval for trial with US Dept of Veterans Affairs
28/04/25	PRICE SENSITIVE	132.57KB	Share
TRI TrivarX Receives Firm Commitments to Raise $2.25 million
17/03/25	PRICE SENSITIVE	137.35KB	Share
TRI Trading Halt
13/03/25	PRICE SENSITIVE	255.86KB	Share
TRI Trial with US Department of Veterans Affairs
13/03/25	PRICE SENSITIVE	137.48KB	Share
TRI Appendix 4D & Half-Year Financial Report to 31 December 2024
28/02/25	PRICE SENSITIVE	855.59KB	Share
TRI December 2024 Quarterly Activities Report and Appendix 4C
31/01/25	PRICE SENSITIVE	377.14KB	Share
TRI TrivarX Receives $1.03m R&D Tax Incentive
06/12/24	PRICE SENSITIVE	116.48KB	Share
TRI New AI Tool Expands Patient Reach and Market Opportunities
07/11/24	PRICE SENSITIVE	179.46KB	Share
TRI September 2024 Quarterly Activities Report and Appendix 4C
30/10/24	PRICE SENSITIVE	379.85KB	Share
TRI Appendix 4E - Preliminary Final Report
29/08/24	PRICE SENSITIVE	340.77KB	Share
TRI June 2024 Quarterly Activities Report and Appendix 4C
31/07/24	PRICE SENSITIVE	403.3KB	Share
TRI Positive Results from Phase 2 SAMDE Study
30/07/24	PRICE SENSITIVE	199.35KB	Share
TRI Trading Halt
29/07/24	PRICE SENSITIVE	256.67KB	Share
TRI TrivarX Receives Firm Commitments to Raise $2.5 million
02/05/24	PRICE SENSITIVE	146.08KB	Share
TRI Trading Halt
30/04/24	PRICE SENSITIVE	255.74KB	Share
TRI March 2024 Quarterly Activities Report and Appendix 4C
29/04/24	PRICE SENSITIVE	384.67KB	Share
TRI Appendix 4D & Half-Year Financial Report to 31 December 2023
28/02/24	PRICE SENSITIVE	773.88KB	Share
TRI Response to ASX Price Query
22/02/24	PRICE SENSITIVE	340.86KB	Share
TRI TrivarX Receives $888k R&D Tax Incentive
08/02/24	PRICE SENSITIVE	102.8KB	Share
TRI TRI-001 Algorithm and Phase 2 Trial Update
05/02/24	PRICE SENSITIVE	160.46KB	Share
TRI December 2023 Quarterly Activities Report and Appendix 4C
31/01/24	PRICE SENSITIVE	275.48KB	Share
TRI Phase 2 SAMDE Study Update
20/11/23	PRICE SENSITIVE	153.22KB	Share
TRI September 2023 Quarterly Activities Report and Appendix 4C
30/10/23	PRICE SENSITIVE	256.22KB	Share
TRI Board and Management Transition
06/10/23	PRICE SENSITIVE	159.19KB	Share
TRI Letter to Shareholders & Notice of GM & Proxy Form
06/09/23	PRICE SENSITIVE	821.04KB	Share
TRI Phase 2 Trial Commences for SAMDE Study
04/09/23	PRICE SENSITIVE	206.53KB	Share
TRI Appendix 4E - Preliminary Final Report
31/08/23	PRICE SENSITIVE	343.63KB	Share
TRI Proposed issue of securities - MEB
07/08/23	PRICE SENSITIVE	34.7KB	Share
TRI Medibio Receives Firm Commitments to Raise $2.25m
07/08/23	PRICE SENSITIVE	190.07KB	Share
TRI Trading Halt
03/08/23	PRICE SENSITIVE	272.13KB	Share
TRI June 2023 Quarterly Activities Report and Appendix 4C
31/07/23	PRICE SENSITIVE	415.98KB	Share
TRI Phase 1 Trial Completed for SAMDE Study
24/07/23	PRICE SENSITIVE	207.02KB	Share
TRI Medibio Completes Share Purchase Plan
29/05/23	PRICE SENSITIVE	149.36KB	Share
TRI March 2023 Quarterly Activities Report and Appendix 4C
27/04/23	PRICE SENSITIVE	399.18KB	Share
TRI MEB Executes Bridging Loans with Directors
21/04/23	PRICE SENSITIVE	143.06KB	Share
TRI Share Purchase Plan Supplementary Prospectus
14/04/23	PRICE SENSITIVE	1.6MB	Share
TRI Share Purchase Plan Prospectus
02/03/23	PRICE SENSITIVE	575.38KB	Share
TRI Half Yearly Report and Accounts
24/02/23	PRICE SENSITIVE	701.09KB	Share
TRI MEB to Raise up to $2.75 million By Way of a Placement & SPP
15/02/23	PRICE SENSITIVE	297.63KB	Share
TRI Trading Halt
10/02/23	PRICE SENSITIVE	244.18KB	Share
TRI Medibio Quarterly Update and Cashflow Report
31/01/23	PRICE SENSITIVE	419.7KB	Share
TRI Medibio Receives R&D Tax Incentive Refund
15/11/22	PRICE SENSITIVE	141.04KB	Share
TRI Medibio Quarterly Update and Cashflow Report
31/10/22	PRICE SENSITIVE	416.29KB	Share
TRI Medibio Appoints CEO
19/09/22	PRICE SENSITIVE	219.57KB	Share
TRI Appendix 4E and Preliminary Final Report
31/08/22	PRICE SENSITIVE	269.04KB	Share
TRI Medibio Quarterly Update and Cashflow Report
01/08/22	PRICE SENSITIVE	398.62KB	Share
TRI Sleep Analysis Depressive Burden Study Clinical Trial
21/07/22	PRICE SENSITIVE	133.4KB	Share
TRI MEB to Raise $1.4m by way of a Placement & MD/CEO Resigns
22/06/22	PRICE SENSITIVE	175.97KB	Share
TRI Reinstatement to Quotation
22/06/22	PRICE SENSITIVE	85.48KB	Share
TRI Voluntary Suspension
16/06/22	PRICE SENSITIVE	208.9KB	Share
TRI Trading Halt
14/06/22	PRICE SENSITIVE	505.79KB	Share
TRI FDA Confirm Diagnostic Method on Depression Validation Trial
18/05/22	PRICE SENSITIVE	218.87KB	Share
TRI Medibio Quarterly Update and Cashflow Report
29/04/22	PRICE SENSITIVE	386.76KB	Share
TRI Medibio Announces Entitlement Offer Result
11/03/22	PRICE SENSITIVE	112.23KB	Share
TRI Termination of Underwriting Agreement
01/03/22	PRICE SENSITIVE	172.77KB	Share
TRI Half Yearly Report and Accounts
25/02/22	PRICE SENSITIVE	603.03KB	Share
TRI Medibio Quarterly Update and Cashflow Report
31/01/22	PRICE SENSITIVE	567.09KB	Share
TRI Non-Renounceable Entitlement Offer Underwriting Update
20/01/22	PRICE SENSITIVE	163.85KB	Share
TRI MEB to Raise up to $5.7 million by way of a Placement & NREO
15/12/21	PRICE SENSITIVE	313.46KB	Share
TRI Trading Halt
10/12/21	PRICE SENSITIVE	333.12KB	Share
TRI Medibio Quarterly Update and Cashflow Report
29/10/21	PRICE SENSITIVE	422.62KB	Share
TRI FDA Strategy and Regulatory Update
26/10/21	PRICE SENSITIVE	294.24KB	Share
TRI Appendix 4E and Annual Report
31/08/21	PRICE SENSITIVE	1.16MB	Share
TRI Medibio Quarterly Update and Cashflow Report
30/07/21	PRICE SENSITIVE	369.51KB	Share
TRI MEB Appoints R&CPMK As Communications Agency in the US
25/06/21	PRICE SENSITIVE	191.45KB	Share
TRI Medibio strengthens its IP protection
04/05/21	PRICE SENSITIVE	138.49KB	Share
TRI Medibio Quarterly Update and Cashflow Report
30/04/21	PRICE SENSITIVE	397.8KB	Share
TRI Re-submission of FDA 510(k) application
29/04/21	PRICE SENSITIVE	159.75KB	Share
TRI Consumer Mental Health App Development - Second Test Phase
22/04/21	PRICE SENSITIVE	167.63KB	Share
TRI MEB Share Purchase Plan Closes Strongly Oversubscribed
31/03/21	PRICE SENSITIVE	181.59KB	Share
TRI Supplementary Prospectus
31/03/21	PRICE SENSITIVE	184.81KB	Share
TRI MEB Begins Implementation of ilumen In the United Kingdom
19/03/21	PRICE SENSITIVE	220.5KB	Share
TRI Share Purchase Plan Prospectus
26/02/21	PRICE SENSITIVE	860.18KB	Share
TRI Half Yearly Report and Accounts
24/02/21	PRICE SENSITIVE	582.16KB	Share
TRI Underwritten Share Purchase Plan Update
15/02/21	PRICE SENSITIVE	167.32KB	Share
TRI MEB to Raise up to $3.5m By Way of a Placement and SPP
10/02/21	PRICE SENSITIVE	260.39KB	Share
TRI Trading Halt
05/02/21	PRICE SENSITIVE	195.53KB	Share
TRI Medibio Quarterly Update and Cashflow Report
29/01/21	PRICE SENSITIVE	433.04KB	Share
TRI Medibio Granted CE Mark Approval for MEBsleep
19/01/21	PRICE SENSITIVE	106.21KB	Share
TRI Consumer Mental Health App Initial testing phase commenced
11/01/21	PRICE SENSITIVE	106.75KB	Share
TRI US FDA advises further data needed for MEBsleep approval
29/12/20	PRICE SENSITIVE	188.85KB	Share
TRI Update on Breakthrough Device Program
03/12/20	PRICE SENSITIVE	108.09KB	Share
TRI Global Master License & Services Agreement with Compass
23/11/20	PRICE SENSITIVE	196.92KB	Share
TRI AGM Presentation
12/11/20	PRICE SENSITIVE	1.19MB	Share
TRI Medibio Quarterly Update and Cashflow Report
29/10/20	PRICE SENSITIVE	225.26KB	Share
TRI MEB Signs Clinical Trial Agreement with MedBridge Healthcare
07/10/20	PRICE SENSITIVE	231.79KB	Share
TRI Request For FDA Breakthrough Device Designation Submitted
02/10/20	PRICE SENSITIVE	142.79KB	Share
TRI FDA Strategy and Regulatory Update
31/08/20	PRICE SENSITIVE	189.16KB	Share
TRI Appendix 4E and Preliminary Final Report
28/08/20	PRICE SENSITIVE	336.33KB	Share
TRI Patent Granted to Monitor Stress Conditions Using Heartrate
10/08/20	PRICE SENSITIVE	177.71KB	Share
TRI FDA Strategy and Regulatory Update
07/08/20	PRICE SENSITIVE	193.82KB	Share
TRI Medibio Quarterly Update and Cashflow Report
30/07/20	PRICE SENSITIVE	453.75KB	Share
TRI Entitlement Issue Results
09/07/20	PRICE SENSITIVE	142.68KB	Share
TRI Entitlement Offer Booklet
10/06/20	PRICE SENSITIVE	605.3KB	Share
TRI Placement and Fully Underwritten Entitlement Offer
10/06/20	PRICE SENSITIVE	166.07KB	Share
TRI Trading Halt
05/06/20	PRICE SENSITIVE	205.31KB	Share

REFRESH

1 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $6.818M

Open	High	Low	Value	Volume
1.2¢	1.2¢	1.1¢	$7.732K	701.4K

Buyers (Bids)

No.	Vol.	Price($)
7	3030000	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	760913	2

View Market Depth

No.	Vol.	Price($)
7	3030000	0.010
8	6886324	0.009
15	3470750	0.008
2	271571	0.007
2	385000	0.006

Price($)	Vol.	No.
0.012	760913	2
0.013	1017587	3
0.014	871302	4
0.015	1195000	4
0.016	1027142	2

Last trade - 13.06pm 16/09/2025 (20 minute delay)


Last 1.1¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
1.2¢	1.2¢	1.1¢	705125
Last updated 10.58am 16/09/2025 ?

TRI (ASX) Chart

TRIVARX LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available